<div>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity. </div><br><div>
<p>In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity. This podcast falls within the Metabolic Problems and Endocrinology curriculum field.</p><p><strong>RCGP Podcast Feedback</strong><br>Your feedback plays a crucial role in helping us improve the CPD products and services we offer. We would be grateful if you could please complete our short <a href="https://r1.dotdigital-pages.com/p/49LX-11EN/rcgppodcasts">RCGP Podcast Survey</a>, which will take no more than <strong>5 minutes</strong> to complete.</p></div>

Endometriosis

The Royal College of General Practitioners is the professional membership body for family doctors in the UK and overseas. This podcast is produced by the RCGP eLearning and Essential Knowledge Update teams and features discussions with clinical experts about a range of key topics in primary care.